For the ATXN1 gene, we observed an increased frequency of IAs in patients with Parkinson’s disease compared with controls, but it was not significant [9.5 versus 6.3%, respectively; P = 0.576, OR (95% CI): 0.64 (0.39–1.02)]. This evidence concerns the gene ATXN1 and Parkinson disease.